Synthesis and Anticancer Activity of Novel Indole Derivatives as DualEGFR/SRC Kinase Inhibitors

Abstract

Overall kinase inhibition, cytotoxicity and apoptosis assays presented that compound 16 has dual inhibitory activity against SRC and EGFR kinases while maintaining low toxicity against normal cells. Other compounds also showed considerable activity profiles in kinase and cell culture assays.